Mohammad Ilyas

University of Nottingham — United Kingdom

Medicine · Health Sciences

48h-index8.5kcitations244works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(78), Genetic factors in colorectal cancer(66), Radiomics and Machine Learning in Medical Imaging(48), Cancer Treatment and Pharmacology(38), Cancer Genomics and Diagnostics(28)

Publications242 total

Supplementary Figure S2 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Supplementary Table S2 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Supplementary Methods S1 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Supplementary Figure S1 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Supplementary Figure S3 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Supplementary Table S1 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Supplementary Table S3 from Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
2025Open Access
Prevalence of Asymptomatic Malaria Infection in Malaria-Endemic Areas of Southeast Asia: A Scoping Review
2025Open Access
COMPARISON OF OPEN VS. MINIMALLY INVASIVE SURGICAL STAGING IN EARLY-STAGE OVARIAN CANCER
Insights-Journal of Health and Rehabilitation·2025Open Access
Microsatellite instability and early onset colorectal cancer in an emerging economy: A study in an Indonesian tertiary hospital.
F1000Research·2025Open Access
Molecular characterization of colorectal cancer: Insights from miRNA, mRNA, and protein analysis
Tumor Discovery·2024Open Access
Supplementary Figure S2 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Figure S1 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Table S1 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Table S2 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Data from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Methods S1 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Table S2 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Methods S1 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
Supplementary Figure S3 from Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer
2024Open Access
page 1 of 13Next →

Frequent Co-authors

Ian Tomlinson(15), Walter F. Bodmer(14), Andrew Rowan(7), Ian Talbot(5), Darryl Jackson(5), Ian O. Ellis(4), Wakkas Fadhil(4), Philip Kaye(4), Abdulkader M. Albasri(4), Victoria Johnson(3), Jason A. Efstathiou(3), Bradley Spencer‐Dene(3), Abdolrahman S. Nateri(3), Jie Shu(3), Guoping Qiu(3), Xingpei Hao(3), S Crook(3), Rashmi Seth(3), Mohammed A. Aleskandarany(3), Ahmed Benhasouna(3)